Veru Inc

NASDAQ:VERU  
4.90
-0.31 (-5.95%)
Products

Veru Announces FDA Approval Of ENTADFI, A New Treatment For Benign Prostatic Hyperplasia

Published: 12/13/2021 13:47 GMT
Veru Inc (VERU) - Veru Announces FDA Approval of Entadfi, a New Treatment for Benign Prostatic Hyperplasia.
Veru Inc - Commercialization of Entadfi Will Start Early Calendar Year 2022.